Prevalence and diagnostic significance of de-novo 12-lead ECG changes after COVID-19 infection in elite soccer players
Raghav T Bhatia,Aneil Malhotra,Hamish MacLachlan,Sabiha Gati,Sarandeep Marwaha,Nikhil Chatrath,Saad Fyyaz,Haroldo Aleixo,Samar Al-Turaihi,Aswin Babu,Joyee Basu,Paul Catterson,Robert Cooper,Joelle J N Daems,Harshil Dhutia,Filipe Ferrari,Juliette C van Hattum,Zafar Iqbal,Alexandros Kasiakogias,Antoinette Kenny,Tamim Khanbhai,Shafik Khoury,Chris Miles,David Oxborough,Kashif Quazi,Dhrubo Rakhit,Anushka Sharma,Amanda Varnava,Maria Teresa Tome Esteban,Gherardo Finocchiaro,Ricardo Stein,Harald T Jorstad,Michael Papadakis,Sanjay Sharma
DOI: https://doi.org/10.1136/heartjnl-2022-322211
IF: 5.7
2023-05-26
Heart
Abstract:Background and aim: The efficacy of pre-COVID-19 and post-COVID-19 infection 12-lead ECGs for identifying athletes with myopericarditis has never been reported. We aimed to assess the prevalence and significance of de-novo ECG changes following COVID-19 infection. Methods: In this multicentre observational study, between March 2020 and May 2022, we evaluated consecutive athletes with COVID-19 infection. Athletes exhibiting de-novo ECG changes underwent cardiovascular magnetic resonance (CMR) scans. One club mandated CMR scans for all players (n=30) following COVID-19 infection, despite the absence of cardiac symptoms or de-novo ECG changes. Results: 511 soccer players (median age 21 years, IQR 18-26 years) were included. 17 (3%) athletes demonstrated de-novo ECG changes, which included reduction in T-wave amplitude in the inferior and lateral leads (n=5), inferior leads (n=4) and lateral leads (n=4); inferior T-wave inversion (n=7); and ST-segment depression (n=2). 15 (88%) athletes with de-novo ECG changes revealed evidence of inflammatory cardiac sequelae. All 30 athletes who underwent a mandatory CMR scan had normal findings. Athletes revealing de-novo ECG changes had a higher prevalence of cardiac symptoms (71% vs 12%, p<0.0001) and longer median symptom duration (5 days, IQR 3-10) compared with athletes without de-novo ECG changes (2 days, IQR 1-3, p<0.001). Among athletes without cardiac symptoms, the additional yield of de-novo ECG changes to detect cardiac inflammation was 20%. Conclusions: 3% of athletes demonstrated de-novo ECG changes post COVID-19 infection, of which 88% were diagnosed with cardiac inflammation. Most affected athletes exhibited cardiac symptoms; however, de-novo ECG changes contributed to a diagnosis of cardiac inflammation in 20% of athletes without cardiac symptoms.